Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,644 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults

NCT00123968

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Kenya Med. Research Inst./Walter Reed Project, Clinical Research Centre, Off Hospital Road. Kericho Kericho, Kenya
  • National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) CRS Mbeya, Tanzania
  • Makerere University Walter Reed Project (MUWRP) Kampala, Uganda
View Trial Details
Completed

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand

NCT00672412

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Prapokklao Hosp. CRS Muang District, Changwat Chanthaburi, Thailand
  • Siriraj Hospital Mahidol University CRS Bangkok, Ratchathewi, Thailand
  • Chiang Mai University Pediatrics-Obstetrics CRS Chiang Mai, Thailand
  • Chonburi Hosp. CRS Chon Buri, Thailand
View Trial Details
Completed

Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

NCT01828073

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program La Jolla, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA NICHD CRS Los Angeles, California, United States
View all 19 locations
View Trial Details
Completed

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

NCT00078403

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +18 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • University of Southern California CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford AIDS Clinical Trials Unit CRS Palo Alto, California, United States
View all 37 locations
View Trial Details
Completed

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

NCT00074425

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 3535 Market Street CRS Philadelphia, Pennsylvania, United States
  • University of North Carolina Lilongwe CRS Lilongwe, Central Region, Malawi
  • College of Med. JHU CRS Blantyre, Southern Region, Malawi
  • Chatsworth CRS Chatsworth, KwaZulu-Natal, South Africa
View Trial Details
Completed

A Safety and Immune Response Study of 2 Experimental HIV Vaccines

NCT02404311

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • CAPRISA eThekwini CRS Durban, KwaZulu-Natal, South Africa
  • Isipingo CRS Durban, KwaZulu-Natal, South Africa
  • Emavundleni Desmond Tutu HIV Centre CRS Cape Town, Western Cape, South Africa
  • Aurum Institute for Health Research Klerksdorp, South Africa
View Trial Details
Completed

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

NCT00074581

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Fenway Community Health Ctr. CRS Boston, Massachusetts, United States
  • Gaborone CRS Gaborone, Botswana
  • Hospital Geral de Nova Iguaçu CRS (HGNI CRS) Nova Iguaçu, Rio de Janeiro, Brazil
  • Hospital Nossa Senhora da Conceicao CRS Port Alegre, Rio Grande do Sul, Brazil
View all 17 locations
View Trial Details
Completed

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

NCT00006604

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB Pediatric Infectious Diseases CRS Birmingham, Alabama, United States
  • Usc La Nichd Crs Alhambra, California, United States
  • University of California, UC San Diego CRS La Jolla, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
View all 36 locations
View Trial Details
Completed

Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

NCT01751568

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • Soweto IMPAACT CRS Johannesburg, Gauteng, South Africa
  • Wits RHI Shandukani Research Centre CRS Johannesburg, Gauteng, South Africa
  • Desmond Tutu TB Centre - Stellenbosch University (DTTC-SU) CRS Cape Town, Western Cape, South Africa
  • Famcru Crs Cape Town, Western Cape, South Africa
View Trial Details

Related conditions